Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Teh, JH"'
Autor:
Aboagye, E, Teh, JH, Amgheib, A, Fu, R, Barnes, C, Abrahams, J, Ashek, A, Wang, N, Yang, Z, Mansoorudeen, M, Long, NJ
C-Met is a receptor tyrosine kinase that is overexpressed in a range of different cancer types, and has been identified as a potential biomarker for cancer imaging and therapy. Previously, a 68Ga-labelled peptide, [68Ga]Ga-EMP-100, has shown promise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::50745820cea24fc90d2b731fa7801514
http://hdl.handle.net/10044/1/105352
http://hdl.handle.net/10044/1/105352
Autor:
Toh TH; Clinical Research Centre, Sibu Hospital, Ministry of Health Malaysia, Sibu, Malaysia.; Faculty of Medicine, SEGi University, Kota Damansara, Malaysia., Qi YY; Shanghai Institute of Infectious Disease and Biosecurity, Shanghai, China.; Key Laboratory of Medical Molecular Virology of MoE & MoH, and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China., Yong SM; Clinical Research Centre, Sibu Hospital, Ministry of Health Malaysia, Sibu, Malaysia., Lee JS; Clinical Research Centre, Sibu Hospital, Ministry of Health Malaysia, Sibu, Malaysia., Liyana NF; Clinical Research Centre, Sibu Hospital, Ministry of Health Malaysia, Sibu, Malaysia., See RY; Divisional Health Office, Ministry of Health Malaysia, Sibu, Malaysia., Teh JH; Divisional Health Office, Ministry of Health Malaysia, Sibu, Malaysia., Toh AZ; Clinical Research Centre, Sibu Hospital, Ministry of Health Malaysia, Sibu, Malaysia., Naing L; PAPRSB Institute of Health Sciences, University Brunei Darussalam, Bandar Seri Begawan, Brunei Darussalam., Dahian K; Clinical Research Centre, Sibu Hospital, Ministry of Health Malaysia, Sibu, Malaysia., Liew JW; Medical Department, Sibu Hospital, Ministry of Health Malaysia, Sibu, Malaysia., Mose CN; Emergency & Trauma Department, Sibu Hospital, Ministry of Health Malaysia, Sibu, Malaysia., Yong MZ; Clinical Research Centre, Sibu Hospital, Ministry of Health Malaysia, Sibu, Malaysia., Ling NJ; Clinical Research Centre, Sibu Hospital, Ministry of Health Malaysia, Sibu, Malaysia., Chua DW; Clinical Research Centre, Sibu Hospital, Ministry of Health Malaysia, Sibu, Malaysia., Ling WW; Emergency & Trauma Department, Sibu Hospital, Ministry of Health Malaysia, Sibu, Malaysia., Thirunavukkarasu N; Director Office, Sibu Hospital, Ministry of Health Malaysia, Sibu, Malaysia., Suhaili MR; Faculty of Medicine, SEGi University, Kota Damansara, Malaysia., Xia JL; Xijing Hospital, Xi'an, China., Clemens J; International Vaccine Institute, Seoul, Korea., Wang XY; Shanghai Institute of Infectious Disease and Biosecurity, Shanghai, China.; Key Laboratory of Medical Molecular Virology of MoE & MoH, and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.; Children's Hospital, Fudan University, Shanghai, China.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Dec 31; Vol. 19 (1), pp. 2167438. Date of Electronic Publication: 2023 Jan 27.
Autor:
Teh JH; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, UK., Amgheib A; Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, London W12 0NN, UK., Fu R; Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, London W12 0NN, UK., Barnes C; Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, London W12 0NN, UK., Abrahams J; Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, London W12 0NN, UK., Ashek A; Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, London W12 0NN, UK., Wang N; Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, London W12 0NN, UK., Yang Z; Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, London W12 0NN, UK., Mansoorudeen M; Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, London W12 0NN, UK., Long NJ; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, UK., Aboagye EO; Department of Surgery and Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, London W12 0NN, UK.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2023 Jul 10; Vol. 15 (7). Date of Electronic Publication: 2023 Jul 10.
Autor:
Braga M; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom., Leow CH; Department of Bioengineering, Faculty of Engineering, Imperial College London, London, United Kingdom., Gil JH; Department of Chemistry, Faculty of Natural Sciences, Imperial College London, London, United Kingdom., Teh JH; Department of Chemistry, Faculty of Natural Sciences, Imperial College London, London, United Kingdom., Carroll L; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom., Long NJ; Department of Chemistry, Faculty of Natural Sciences, Imperial College London, London, United Kingdom., Tang MX; Department of Bioengineering, Faculty of Engineering, Imperial College London, London, United Kingdom., Aboagye EO; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.
Publikováno v:
PloS one [PLoS One] 2021 Nov 18; Vol. 16 (11), pp. e0260186. Date of Electronic Publication: 2021 Nov 18 (Print Publication: 2021).
Autor:
Teh JH; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, UK. n.long@imperial.ac.uk.; Department of Surgery & Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, UK. eric.aboagye@imperial.ac.uk., Braga M; Department of Surgery & Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, UK. eric.aboagye@imperial.ac.uk., Allott L; Department of Surgery & Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, UK. eric.aboagye@imperial.ac.uk.; Positron Emission Tomography Research Centre, Faculty of Health Sciences, University of Hull, UK., Barnes C; Department of Surgery & Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, UK. eric.aboagye@imperial.ac.uk., Hernández-Gil J; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, UK. n.long@imperial.ac.uk.; Department of Surgery & Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, UK. eric.aboagye@imperial.ac.uk., Tang MX; Department of Bioengineering, Imperial College London, UK., Aboagye EO; Department of Surgery & Cancer, Imperial Centre for Translational and Experimental Medicine, Imperial College London, UK. eric.aboagye@imperial.ac.uk., Long NJ; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, UK. n.long@imperial.ac.uk.
Publikováno v:
Chemical communications (Cambridge, England) [Chem Commun (Camb)] 2021 Nov 04; Vol. 57 (88), pp. 11677-11680. Date of Electronic Publication: 2021 Nov 04.